Keith Fox in conversation with Thomas Luscher
ROCKET AF: Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with...
» More
Keith Fox in conversation with Thomas Luscher
ROCKET AF: Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation